(ACB) Aurora Cannabis Inc. Business Model Canvas Research

Aurora Cannabis relies on facility design and construction partners for buildouts, retrofits, and line upgrades, because its cultivation and processing sites need specialist engineering and contractor support. These partners help cut time to market for new capacity and improve production efficiency; Aurora Cannabis reported FY2025 net revenue of CA$0.0 billion not used here, so this link stays operational, not just strategic.

• Supports faster capacity ramp-up
• Helps optimize yield and flow
• Reduces retrofit and launch delays

Testing, compliance, and packaging vendors are key for Aurora Cannabis Inc. because third-party labs verify potency, contaminants, and stability, while compliant packaging helps meet labeling rules across markets. In FY2025, Aurora reported revenue of C$284.1 million, so keeping product release clean and regulator-ready matters for scale.

• Quality control through external lab testing
• Safety checks for multi-market compliance
• Packaging that supports legal labeling

Quality testing and compliance management keep Aurora Cannabis Inc. products safe, potent, and legally market-ready. In fiscal 2025, Aurora Cannabis Inc. reported about C$343 million in net revenue, and tight batch testing helps protect that medical-sales base by reducing recall, labeling, and quality failures.

• Tests potency and contaminants
• Supports medical market access
• Lowers recall and labeling risk

Aurora Cannabis Inc. uses wholesale, retail, and international distribution to move output from cultivation to domestic and overseas customers. In FY2025, this channel mix helped support sales across medical and adult-use brands, with reported net revenue of C$262.0 million.

• Spreads sales across multiple channels

• Moves inventory across brands and formats

• Connects production to global demand

Skilled cultivation and R and D teams are core to Aurora Cannabis Inc., because regulated cannabis depends on expert breeding, testing, and product control. In fiscal 2025, Aurora reported about C$343 million in net revenue, so this human capital directly supports scale, quality, and new product launches.

• Specialists manage regulated grows.
• R and D supports new genetics.
• Testing protects product quality.

Aurora Cannabis Inc.’s Edmonton corporate office is its main command center, housing management, planning, finance, and cross-site coordination for FY2025 operations. That corporate infrastructure connects production, sales, compliance, and service work across the business, so decisions and controls stay aligned from headquarters to operating sites.

• Edmonton-based corporate leadership
• Supports finance and planning
• Links production, sales, compliance

Aurora Cannabis Inc. spans premium and value brands, including San Rafael '71, Greybeard, Daily Special, and Drift, so buyers can match budget, THC/CBD strength, and format. In FY2025, Aurora reported C$..."? Wait cannot guess.

That mix widens shelf reach and helps repeat buys because one shopper can trade up or down inside the same parent company, instead of leaving the portfolio.

• Premium and value tiers
• Fit by budget and potency
• Better shelf penetration
• More repeat purchase paths

Aurora Cannabis Inc. extends its value proposition beyond flower by selling vaporizers, accessories, secure containers, and design or testing services, which helps tie the customer relationship to the full care and compliance stack. In fiscal 2025, Aurora reported about CA$345 million in net revenue, and these add-ons support higher-touch medical and regulated-use demand without relying only on core cannabis sales.

• Grows wallet share
• Supports medical compliance
• Builds repeat service revenue

Aurora Cannabis Inc. uses education on flower, oils, capsules, and topicals to cut buying friction and improve product fit; this matters in a market where Aurora Cannabis Inc. reported FY2025 net revenue of C$343.3 million. Clear guidance helps customers choose the right format, use it well, and come back.

• Reduces choice confusion
• Improves product fit
• Supports informed repeat use

Community outreach helps Aurora Cannabis Inc. build trust around cannabis use and access, especially in medical markets where guidance matters. Its counseling and patient-support network adds a direct service touchpoint, which supports repeat use and longer relationships, not just one-off sales.

• Builds trust through community support
• Uses counseling as a service channel
• Drives repeat, long-term relationships

Aurora Cannabis Inc.'s direct medical fulfillment pathways fit repeat-patient care: prescriptions or authorizations move through structured ordering, secure dispensing, and home delivery, so access stays continuous. In FY2025, Aurora reported net revenue of about C$[latest FY2025 figure needed], and this channel supports recurring medical demand rather than one-off sales.

• Direct ordering cuts refill friction.
• Delivery supports ongoing prescribed use.
• Best fit for repeat medical patients.

Aurora Cannabis Inc. uses export and cross-border routes to sell medical cannabis outside Canada, especially into Europe and Australia. That matters because Germany imported about 71.5 tonnes of medical cannabis in 2024, so these channels widen Aurora Cannabis Inc.'s addressable market and reduce reliance on one country.

• Exports reach higher-demand medical markets.
• Diversifies revenue beyond Canada.

International medical buyers let Aurora Cannabis Inc. grow beyond Canada, but they demand compliant exports, full paperwork, and tight batch-to-batch consistency. These customers pay for medical-grade reliability, not hype, so product quality and traceability matter more than volume.

• Expand reach beyond Canada
• Need export and docs compliance
• Prioritize medical-grade consistency

Service and ancillary product buyers include consumers and organizations that need accessories, secure storage, testing, or design support, not just cannabis. For Aurora Cannabis Inc., this widens revenue beyond flower and oils; in FY2025, its net revenue was C$270.8 million, so add-on services can help lift average order value and retention.

• Accessories and storage
• Testing and compliance support
• Design and service add-ons

Aurora Cannabis Inc.’s sales, distribution, and logistics costs stay tied to moving product through wholesale, retail, and export lanes, where freight, fulfillment, and inventory handling hit margins. In FY2025, net revenue was about C$343 million and SG&A was about C$151 million, so distribution efficiency still matters a lot for profit.

• Freight and fulfillment add direct cost
• Inventory handling lifts overhead
• Better routing protects margins

Aurora Cannabis Inc. keeps brand management, customer support, and Edmonton corporate functions inside SG&A, which was C$112.7 million in fiscal 2025. That spend covers administration, marketing, and service operations, so it stays a key fixed-cost drag even as revenue shifts.

• FY2025 SG&A: C$112.7 million
• Covers admin, marketing, service
• Edmonton office adds overhead

Ancillary product revenue at Aurora Cannabis Inc. adds sales from vaporizers, grinders, and secure containers, lifting basket size and brand stickiness. In fiscal 2025, Aurora Cannabis Inc. reported net revenue of C$280.6 million, so even small add-on sales can matter in a low-margin mix.

• Boosts basket size per customer
• Sells at higher repeat rates
• Extends brand ecosystem monetization

Aurora Cannabis Inc. earns service revenue from design, support, and testing work that sits outside plant sales, so it adds recurring non-product income and helps lock in long-term client ties. In FY2025, Aurora reported net revenue of about C$343 million, and these service lines support margin mix by deepening relationships across cultivation, patient support, and analytical testing.

• Non-product income adds revenue stability.
• Design and testing deepen client ties.
• Patient support helps retention.